Cutaneous mucormycosis of the head and neck with parotid gland involvement: First report of a case

Ear, Nose and Throat Journal

Volumn 83, Issue 4, 2004, Pages 282-288

  Numa, William A ^a   Foster, Paul K ^a   Wachholz, Jeffrey ^a   Civantos, Francisco ^a   Gomez Fernandez, Carmen ^a   Weed, Donald T ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; GLUCOSE;

ADULT; ARTICLE; BIOPSY TECHNIQUE; CASE REPORT; DEBRIDEMENT; DERMATOMYCOSIS; DISEASE ASSOCIATION; FACE TUMOR; FACIAL NERVE DISEASE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; MALE; MUCORMYCOSIS; MYCOSIS; OTORHINOLARYNGOLOGY; OUTCOMES RESEARCH; PAROTID GLAND CANCER; PAROTIDECTOMY; RISK FACTOR; SURGICAL TECHNIQUE;

EID: 2042417362     PISSN: 01455613     EISSN: None     Source Type: Journal    
DOI: 10.1177/014556130408300420     Document Type: Article

References (19)

1. Wirth F, Perry R, Schwalbe R, Kao G. Cutaneous mucormycosis with subsequent visceral dissemination in a child with neutropenia: A case report and review of the pediatric literature. J Am Acad Dermatol 1997;36:336-41.
2. Sugar AM. Agents of mucormycosis and related species. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell, Douglas and Bennett's Principles and Practice of Infectious Diseases. 4th ed. New York: Churchill Livingstone, 1995:2311-21.
3. Mucormycosis. Ann Intem Med 1980;93:93-108.
4. Parfrey NA. Improved diagnosis and prognosis of mucormycosis. A clinicopathological study of 33 cases. Medicine (Baltimore) 1986;65:113-23.
5. Adam RD, Hunter G, DiTomasso J, Comerci G Jr. Mucormycosis: Emerging prominence of cutaneous infections. Clin Infect Dis 1994; 19:67-76.
6. Hicks WL, Jr., Nowels K, Troxel J. Primary cutaneous mucormycosis. Am J Otolaryngol 1995; 16:265-8.
7. Patino JF, Castro D, Valencia A, Morales P. Necrotizing soft tissue lesions after a volcanic cataclysm. World J Surg 1991; 15:240-7.
8. Macdonell RA, Donnan GA, Kalnins RM, et al. Otocerebral mucormycosis - a case report. Clin Exp Neurol 1987;23:225-32.
9. Waldorf AR, Ruderman N, Diamond RD. Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus. J Clin Invest 1984;74:150-60.
10. Tierney MR, Baker AS. Infections of the head and neck in diabetes mellitus. Infect Dis Clin North Am 1995;9:195-216.
11. Andrews DR, Allan A, Larbalestier RI. Tracheal mucormycosis. Ann Thorac Surg 1997;63:230-2.
12. Yun MW, Lui CC, Chen WJ. Facial paralysis secondary to tympanic mucormycosis: Case report. Am J Otol 1994;15:413-14.
13. Brown OE, Finn R. Mucormycosis of the mandible. J Oral Maxillofac Surg 1986;44:132-6.
14. Gussen R, Canalis RF. Mucormycosis of the temporal bone. Ann Otol Rhinol Laryngol 1982;91:27-32.
15. Vessely MB, Zitsch RP III, Estrem SA, Renner G. Atypical presentations of mucormycosis in the head and neck. Otolaryngol Head Neck Surg 1996; 115:573-7.
16. Umbert IJ, Su WP. Cutaneous mucormycosis. J Am Acad Dermatol 1989;21:1232-4.
17. Meyer RD, Kaplan MH, Ong M, Armstrong D. Cutaneous lesions in disseminated mucormycosis. JAMA 1973;225:737-8.
18. Maniglia AJ, Mintz DH, Novak S. Cephalic phycomycosis: A report of eight cases. Laryngoscope 1982;92:755-60.
19. Herbrecht R. The changing epidemiology of fungal infections: Are the lipid-forms of amphotericin B an advance? Eur J Haematol Suppl 1996;57:12-17.